If we have selected the wrong experience for you, please change it above.
GenAI can reshape how risk is understood and managed. But its impact differs across the first, second and third lines. Used poorly, it becomes another efficiency tool that creates confusion. Done well, it reshapes risk management across the firm. This overview introduces three standalone articles on those differences.
Business teams move quickly. Risk teams move carefully. The result is friction: persistent, costly and often invisible until it shows up as delays, rework or control gaps. The challenge is not a lack of effort or intent. It is a design problem. Risk knowledge often sits with specialists, while the people closest to day-to-day decisions do not always have timely access.
GenAI offers a different approach: not another tool in another portal, but a way to make risk understanding available where decisions are made.
The first article explores how GenAI can close the knowledge gap, embed risk capability into business workflows and sustain the benefits through disciplined governance.
There is an inherent tension in the second line’s relationship with GenAI. The second line exists to provide independent oversight: to challenge, test and assess whether the firm’s risks are genuinely understood. When a function built on scepticism starts relying on technology it cannot fully interrogate, the question becomes unavoidable: can an oversight function depend on a tool it must also question?
The deeper challenge is fragmentation. Oversight is often spread across domains, teams and jurisdictions that do not always see the same picture or apply the same standard. GenAI can create coherence. But only if the second line is clear about how the technology is governed, challenged and relied upon.
The second article explores how GenAI can create coherence across fragmented oversight without weakening the second line’s independence, credibility or ability to challenge.
Internal audit has always worked under a structural constraint. It must provide assurance over the whole firm while examining only part of the activity. It samples, reasoning from the part to the whole. That approach is established, but it has limits. Concentrated risks, rare events, misconduct or control failures can remain outside the sample until they surface elsewhere.
GenAI and related data techniques now make it possible, in a growing range of cases, to examine entire populations rather than samples. That shift changes how audit plans its work, gathers evidence and supports its conclusions. It also raises a challenge: Audit is increasingly expected to provide assurance over AI while using AI in its own work.
The third article explores what changes when internal audit can examine whole populations instead of samples, and how GenAI can strengthen assurance without weakening independence.
Each line faces a version of the same underlying question: can a function that exists to provide assurance, oversight or challenge depend on a tool it should also scrutinise?
The answer is yes, but only if the function is clear about what it is trying to achieve and disciplined in how it uses the technology.
For the first line, the return can be measured in reduced friction and faster decision-making. For the second line, it is about coherence and credibility. For the third line, it lies in the strength and defensibility of assurance.
In each case, the benefits of Generative AI are real, but they depend on the function maintaining control of its own standards and remaining accountable for its conclusions.
The difference is not in the technology alone. It is in how each function understands its role.
The series offers three focused examinations of how GenAI changes the work of each line. Each article:
The articles are written for leaders and practitioners in risk, compliance, audit, and governance functions. They assume familiarity with the three-lines model and with the regulatory environment in which these functions operate. They do not assume technical knowledge of GenAI.